Who are Wellesleypharma's investors?

Wellesleypharma's investors include Keiretsu Forum.

How much funding has Wellesleypharma raised?

Wellesleypharma has disclosed $4.7M raised across 2 rounds.

Where is Wellesleypharma headquartered?

Wellesleypharma is headquartered in Newtown, US.

Wellesleypharma

Newtown, US · Founded 2011 · 1 known investors

Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.

BiotechDigital Health

Founders & leadership

David Alan DillChief Executive Officer and President

Investors · 1

Keiretsu ForumSan Francisco · $250K – $2M

Reported raises · per SEC filings

Form D private placements

$4.7M disclosed across 2 rounds · 2014–2015

▶$3.8MraisedOct 2017 · 14 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Christopher LineberryDirector
Candan KarabagliDirector
Omer KarahanDirector
David Alan DillExecutive Officer, Director

Offering amount: $5.8M
Amount sold: $3.8M
Sales commissions: $150K
Placement agents: Healthcare Capital and Mergers
First sale: Mar 2015
Incorporated: Limited Liability Company, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$934.9KraisedFeb 2015 · 18 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

David Alan DillExecutive Officer, Director

Offering amount: $3.4M
Amount sold: $934.9K
Minimum investment: $25K
First sale: Jul 2014
Incorporated: Limited Liability Company, Delaware, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Wellesleypharma do?: Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.
Who are Wellesleypharma's investors?: Wellesleypharma's investors include Keiretsu Forum.
How much funding has Wellesleypharma raised?: Wellesleypharma has disclosed $4.7M raised across 2 rounds.
Where is Wellesleypharma headquartered?: Wellesleypharma is headquartered in Newtown, US.